-
Gland Pharma
2,969.85 3,039.00(%) -
Power Fin.Corpn.
357.70 486.45(%) -
IFCI
107.45 107.45(%) -
Shriram Finance
1,036.40 584.25(%) -
Tata Technolog.
796.45 507.50(%) -
ESDS Software
895.55 895.55(%) -
Lenskart Solut.
694.75 694.75(%) -
Netweb Technol.
5,170.00 2,514.75(%) -
Lumino Inds
122.00 122.00(%) -
Kesar India
1,180.00 1,341.00(%) -
Multi Comm. Exc.
3,287.00 3,479.80(%) -
Tejas Networks
623.90 644.75(%) -
RBL Bank
417.00 417.00(%) -
ICICI AMC
2,960.00 2,528.90(%) -
Polycab India
8,254.00 6,660.50(%) -
New India Assura
234.60 234.60(%) -
Wockhardt
2,107.95 2,420.00(%) -
Angel One
308.20 360.20(%) -
Jindal Worldwide
57.06 57.06(%) -
Lalithaa Jewel
308.55 308.55(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Polson Ltd Chemicals
- Indian Private
- BSE Code : 8002.0
- ISIN : INE339F01021
-
Today’s Low
10,910.70 -
Today’s High
11,500.00
-
Open
11,222.00 -
Perv Close
11,484.90 -
52W Low
9,530.00 -
52W High
12,643.10
Key Indicators
-
P/E(TTM)
26.95
-
Mar.Cap (₹Cr.)
138.00
-
Div & Yield %
0.00
-
Book Value(₹)
10,927.50
-
Debt-Equity Ratio
0.13
-
AGM Date
04-Sep-2026
-
EPS
426.71
-
P/E Ratio
26.95
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
138.00
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
0.60
-
BV (₹)
10,927.50
-
Sales( ₹ in Cr.)
91.16
-
NP (in Cr.)
4.74
-
NP Var(%)
0.0
-
Div%
0.0
-
CPS (₹)
930.60
-
EPS (₹)
395.20
-
Traded Value (₹ in Lakhs)
138.00
-
52 Week High
12,643.10
-
52 Week Low
9,530.00
-
Price BSE
11500.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
138.00
-
P/C Ratio
12.40
-
P/E Ratio
29.10
-
Price Vs.BV
395.20
-
01-Jun-2026( 07:26)
Results - Announcements - Polso... - Net profit of Polson declined...
-
19-May-2026( 11:38)
Corporate News - Polso... - Polson will hold a meeting of...
-
14-Feb-2026( 02:26)
Results - Announcements - Polso... - Net profit of Polson declined...
-
04-Feb-2026( 02:37)
Corporate News - Polso... - Polson will hold a meeting of...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 93.28 | 96.39 | 83.86 | 97.53 | 88.61 | 96.70 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 93.28 | 96.39 | 83.86 | 97.53 | 88.61 | 96.70 |
| Other Income | 1.85 | 1.32 | 3.43 | 2.73 | 3.98 | 4.87 |
| Stock Adjustments | 0.33 | -0.03 | -3.52 | 4.67 | 0.11 | -3.79 |
| Total Income | 95.46 | 97.68 | 83.77 | 104.93 | 92.70 | 97.78 |
| EXPENDITURE : | ||||||
| Raw Materials | 39.60 | 41.71 | 35.55 | 46.42 | 36.02 | 41.35 |
| Power and Fuel Cost | 1.87 | 1.57 | 1.37 | 1.45 | 1.39 | 1.55 |
| Employee Cost | 5.92 | 5.76 | 5.32 | 5.32 | 4.56 | 5.31 |
| Other Manufacturing Expenses | 12.52 | 12.75 | 10.51 | 19.04 | 16.44 | 16.56 |
| Selling and Administration Expenses | 18.32 | 17.09 | 11.61 | 13.01 | 9.22 | 11.49 |
| Miscellaneous Expenses | 0.37 | 1.68 | 1.70 | 1.40 | 5.43 | 0.08 |
| Employee Benefit Expenses | 5.92 | 5.76 | 5.32 | 5.32 | 4.56 | 5.31 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 78.60 | 80.56 | 66.06 | 86.64 | 73.08 | 76.34 |
| Operating Profit | 16.86 | 17.13 | 17.71 | 18.29 | 19.62 | 21.44 |
| Interest | 3.67 | 4.06 | 5.55 | 4.47 | 5.71 | 6.50 |
| Gross Profit | 13.19 | 13.07 | 12.16 | 13.82 | 13.91 | 14.94 |
| Depreciation | 6.06 | 5.75 | 5.51 | 5.13 | 4.77 | 4.53 |
| Profit Before Tax | 7.13 | 7.32 | 6.65 | 8.69 | 9.14 | 10.41 |
| Current Tax | 1.60 | 1.75 | 1.35 | 2.19 | 2.38 | 2.67 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.31 | 0.37 | 0.47 | 0.26 | -1.77 | 0.64 |
| Reported Net Profit | 5.23 | 5.20 | 4.83 | 6.23 | 8.53 | 7.10 |
| Extraordinary Items | 0.48 | -0.06 | 0.89 | 0.08 | 0.03 | -0.01 |
| Adjusted Net Profit | 4.75 | 5.26 | 3.94 | 6.15 | 8.50 | 7.11 |
| Adjustment below Net Profit | 0.01 | 0.03 | 0.01 | 0.03 | 0.02 | -1.51 |
| P & L Balance brought forward | 111.77 | 106.54 | 101.70 | 95.44 | 86.89 | 81.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 117.01 | 111.77 | 106.54 | 101.70 | 95.44 | 86.89 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 435.91 | 433.09 | 402.46 | 519.12 | 710.99 | 591.52 |
| Earnings Per Share(Adj)-Unit Curr | 435.91 | 433.09 | 402.46 | 519.12 | 710.99 | 591.52 |
| Book Value | 10,551.07 | 10,136.14 | 9,681.35 | 9,265.92 | 8,730.82 | 8,019.25 |
| Book Value(Adj)-Unit Curr | 10,551.07 | 10,136.14 | 9,681.35 | 9,265.92 | 8,730.82 | 8,019.25 |
